Integration of Artificial Intelligence and CRISPR/Cas9 System for Vaccine Design

The CRISPR/Cas9 system offers a new approach to genome editing and cancer treatment. This approach is able to detect drug targets and genomic analysis of cancer. The use of artificial intelligence (AI) capacity to edit genomes through CRISPR/Cas9 enables modification of gene mutations, molecular sim...

Descripción completa

Detalles Bibliográficos
Autor principal: Maserat, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703516/
https://www.ncbi.nlm.nih.gov/pubmed/36452267
http://dx.doi.org/10.1177/11769351221140102
_version_ 1784839871649546240
author Maserat, Elham
author_facet Maserat, Elham
author_sort Maserat, Elham
collection PubMed
description The CRISPR/Cas9 system offers a new approach to genome editing and cancer treatment. This approach is able to detect drug targets and genomic analysis of cancer. The use of artificial intelligence (AI) capacity to edit genomes through CRISPR/Cas9 enables modification of gene mutations, molecular simulation. AI approaches include knowledge discovery approaches, antigen and epitope prediction approaches, and agent based-model approaches. These methods in combination with CRISPR/Cas9 can be used in vaccine design.
format Online
Article
Text
id pubmed-9703516
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-97035162022-11-29 Integration of Artificial Intelligence and CRISPR/Cas9 System for Vaccine Design Maserat, Elham Cancer Inform Editorial The CRISPR/Cas9 system offers a new approach to genome editing and cancer treatment. This approach is able to detect drug targets and genomic analysis of cancer. The use of artificial intelligence (AI) capacity to edit genomes through CRISPR/Cas9 enables modification of gene mutations, molecular simulation. AI approaches include knowledge discovery approaches, antigen and epitope prediction approaches, and agent based-model approaches. These methods in combination with CRISPR/Cas9 can be used in vaccine design. SAGE Publications 2022-11-26 /pmc/articles/PMC9703516/ /pubmed/36452267 http://dx.doi.org/10.1177/11769351221140102 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Editorial
Maserat, Elham
Integration of Artificial Intelligence and CRISPR/Cas9 System for Vaccine Design
title Integration of Artificial Intelligence and CRISPR/Cas9 System for Vaccine Design
title_full Integration of Artificial Intelligence and CRISPR/Cas9 System for Vaccine Design
title_fullStr Integration of Artificial Intelligence and CRISPR/Cas9 System for Vaccine Design
title_full_unstemmed Integration of Artificial Intelligence and CRISPR/Cas9 System for Vaccine Design
title_short Integration of Artificial Intelligence and CRISPR/Cas9 System for Vaccine Design
title_sort integration of artificial intelligence and crispr/cas9 system for vaccine design
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703516/
https://www.ncbi.nlm.nih.gov/pubmed/36452267
http://dx.doi.org/10.1177/11769351221140102
work_keys_str_mv AT maseratelham integrationofartificialintelligenceandcrisprcas9systemforvaccinedesign

Ejemplares similares